Roots Analysis

APRIL 5, 2023

Given the limitations of viral transfection as well as the apparent immunogenicity and cytotoxicity concerns associated with these vectors , demand for alternative gene drug vehicles is increasing. Currently, highest number of patent for non-viral transfection reagents and systems is filed in North America region.

Reagent 52

Reagent Marketing Gene Therapy Gene 52

Drug Discovery World

MARCH 27, 2023

Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell therapy The post Diving deep into cell therapy: An industry perspective appeared first on Drug (..)

Reagent 52

Reagent Manufacturing Development Drugs 52

Drug Discovery World

OCTOBER 1, 2022

With an unrivalled research product portfolio and end-to-end manufacturing services, we are science led and customer focused to solve problems and deliver key reagents across complex chemicals, peptides and key biologics all from one trusted partner.

Reagent 52

Reagent Life Science Manufacturing Production 52

Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. GenScript will provide various CRISPR reagents to support the development of the universal CAR-T products from discovery to commercialisation.

Reagent 52

Reagent Development Gene Editing Production 52

Drug Discovery World

MARCH 27, 2023

Learn more about the trends, insights, and perspectives from ACROBiosystems as a manufacturer of cell therapy reagents, including topics like: CAR-NK research Developing new CAR constructs Evaluation CAR expression detection Role of GMP Manufacturing in cell therapy Download now.

Reagent 52

Reagent Manufacturing Development Research 52

Drug Discovery World

MAY 2, 2023

The winners will receive a MagicPrep NGS instrument only, no reagents or consumables are included. The post Competition: Win a MagicPrep NGS instrument with Tecan appeared first on Drug Discovery World (DDW). Not for use in diagnostic procedures. Submit your abstract.

Reagent 52

Reagent Research Production Drugs 52

Drug Discovery World

NOVEMBER 22, 2022

The latest range of antigens can be used in immunoassay development and as immunogens, and includes reagents for both influenza A and B. . The post New range of influenza antigens for vaccine development appeared first on Drug Discovery World (DDW).

Vaccination 52

Vaccination Vaccine Development Reagent 52

FDA Law Blog

JANUARY 4, 2023

The purpose of these town halls are to discuss topics related to OTAT-regulated products, engage with product development stakeholders, and to provide information to help stakeholders to help advance drug development. The Agency also recommended not using substantial manipulations at a clinical site for already released final drug product.

Reagent 59

Reagent Manufacturing Production Gene Therapy 59

Drug Discovery World

OCTOBER 18, 2023

They are smaller, which makes them more suitable for cross-linking, and this size, coupled with their stability and high affinity for platelet receptors, makes them ideal reagents for receptor imaging.” Reagents based on nanobodies will increase our understanding of platelet activation in the laboratory.

Research 52

Research Reagent In-Vivo Antibody 52

Drug Discovery World

AUGUST 30, 2023

Founded in 1998 and headquartered in Cambridge, UK, Abcam provides antibodies, reagents, biomarkers and assays for drug discovery, life sciences research, and diagnostics. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World The post Danaher to acquire Abcam appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Reagent Branding Antibody 52

Drug Discovery World

NOVEMBER 2, 2023

In her presentation, Jenny Barnett will discuss how we can use non-invasive digital biomarkers to measure abnormalities in brain processes and find homogeneous subgroups of patients, getting the right patient on the right drug. The post Innovative advances in neuroscience: Secure your place appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 26, 2023

In her presentation, Jenny Barnett will discuss how we can use non-invasive digital biomarkers to measure abnormalities in brain processes and find homogeneous subgroups of patients, getting the right patient on the right drug. The post Innovation in neuroscience: Hear from the experts appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 19, 2023

In her presentation, Jenny Barnett will discuss how we can use non-invasive digital biomarkers to measure abnormalities in brain processes and find homogeneous subgroups of patients, getting the right patient on the right drug. The post Discover the latest advances in neuroscience appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

OCTOBER 13, 2022

The DDW team spent 4-5 October, 2022 at ELRIG’s annual meeting, Drug Discovery 2022, which remains Europe’s largest meeting for life sciences industry professionals and took place at ExCel, London, UK. Drug Discovery 2022: The numbers . Drug Discovery 2022: The numbers . Of those delegates, 75% work in drug discovery.

Drugs 52

Drugs In-Vivo In-Vitro Biobanking 52

Drug Discovery World

OCTOBER 12, 2023

In her presentation, Jenny Barnett will discuss how we can use non-invasive digital biomarkers to measure abnormalities in brain processes and find homogeneous subgroups of patients, getting the right patient on the right drug. The post New online event: Innovative advances in neuroscience appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Drugs Development Medicine 52

Drug Discovery World

SEPTEMBER 15, 2022

Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development. You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Reagent 52

Reagent Production Drugs Development 52

Drug Discovery World

SEPTEMBER 15, 2022

Urmi Roy, Global Product Manager for Flow Cytometry Reagents, Miltenyi Biotec, explains why immunogenicity prediction is a key consideration for therapeutic development. You can also find The Drug Discovery World Podcast on Spotify , Google Play and Apple Podcasts.

Reagent 52

Reagent Production Drugs Development 52

Drug Discovery World

FEBRUARY 6, 2023

Medicinal chemists who have a subscription can now connect to CAS SciFinder from within the Torx platform to perform literature and patent reviews to uncover key insights, and mine chemical substances, reagents, and reaction schemes to devise synthetic plans using the CAS SciFinder advanced search, visualisation, filtering and analysis capabilities.

Reagent 52

Reagent Drugs Medicine Research 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

API peptides and proteins-based drugs have gained much attention in the past decade. Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.

Protein 130

Protein Marketing Manufacturing Reagent 130

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

Drug Discovery World

MAY 10, 2023

Based on two words, ‘revolutionise’ (rev) and ‘vita’ (vit) meaning ‘life’ in Latin, Revvity will provide reagents, consumables, assays, instruments and software to customers from pharma and biotech, diagnostic labs, academia and government agencies. Revvity has now officially launched as a science-based solutions company.

Life Science 52

Life Science Reagent Genome Genomics 52

BioTech 365

SEPTEMBER 8, 2020

an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced today key members of the leadership team hired to direct Invivoscribe Therapeutics, Inc., its fully integrated drug development engine. Invivoscribe Therapeutics … Continue reading →

Reagent 52

Reagent Engineer Production Development 52

Drug Discovery World

SEPTEMBER 25, 2023

The post Partners working to realise the future of genomic medicine appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Gene Editing Medicine 52

XTalks

OCTOBER 7, 2020

With the need for COVID-19 testing growing amid the second wave of the pandemic, LabCorp (NYSE: LH) has received an emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its high-speed COVID-19 test. This will help reduce both the materials and time required to complete molecular COVID-19 tests.

Reagent 98

Reagent RNA Life Science FDA Approval 98

Drug Discovery World

MAY 7, 2024

It is up to the end-users and vendors to collaborate and put forth innovative solutions that will aid in driving quicker and more robust mAb production for complex biological processes, leading to quicker and cheaper drug product for patients. at the University of Minnesota in Twin Cities and his B.S

Antibody 59

Antibody Production Manufacturing Engineer 59

Drug Discovery World

JANUARY 30, 2024

Results you can trust The final stage of the all the work ­– from sample preparation to assay development – the optimisation of reagents, buffers, cell lines all come together to display the results. The post High-performance microplates for discovery sciences appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Contamination Production Drugs 52

Drug Discovery World

SEPTEMBER 28, 2022

Winners will be evaluated based on criteria that include research objective, genomic reagent request, and how the product would be used in the field of research. . The post Up to 8 recipients to be awarded grants for genomic research appeared first on Drug Discovery World (DDW).

Genome 52

Genome Genomics Research Life Science 52

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Camargo

JUNE 9, 2021

Drugs are delivered to where they need to go in the human body through any number of ROAs, by using orifices (such as oral or nasal delivery) or administering parenteral injections (such as intramuscular delivery). Intravesical administration involves introducing a urethral catheter to deliver a drug close to its target organ: the bladder.

Reagent 178

Reagent Production Drugs Allergies 178

Drug Discovery World

FEBRUARY 9, 2023

Cytek Biosciences and Bio-Rad Laboratories have entered into a strategic development partnership. Under the terms of the agreement, Bio-Rad’s new StarBright Dyes will be available to Cytek to develop and commercialise reagent products to support high-parameter applications on Aurora and Northern Lights flow cytometry systems.

Reagent 52

Reagent Development Production Marketing 52

Drug Discovery World

SEPTEMBER 29, 2022

Challenges in outsourcing drug discovery. The goal of drug discovery is clear: Identify the most promising leads in the shortest amount of time. Alternatively, some targets require novel, innovative solutions that may not be accessible in conventional drug discovery labs. Minimising reagent consumption and costs.

Reagent 52

Reagent DNA Scientist Drugs 52

Drug Discovery World

JANUARY 10, 2023

Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. The post Sponsored content: Why choose Bethyl antibodies for your R&D appeared first on Drug Discovery World (DDW).

Antibody 52

Antibody Protein Reagent Scientist 52

Drug Discovery World

JANUARY 20, 2023

Results you can trust The final stage of the all the work – from sample preparation to assay development and the optimisation of reagents, buffers, cell lines – all come together to display the results. The post High performance microplates for discovery sciences appeared first on Drug Discovery World (DDW).

Reagent 52

Reagent Contamination Production Development 52

Roots Analysis

FEBRUARY 21, 2022

Moreover, the manual protocols require extensive manipulation, costly reagents and long duration of skilled genomic library production. As a result, NGS library preparation kits have emerged as an innovative technology to overcome the challenges associated with conventional library preparation protocols. Nanoparticles Contract Manufacturing.

Marketing 52

Marketing Gene Sequencing DNA Genome 52

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. Market Landscape of mRNA Synthesis Kits Presently more than 95 mRNA synthesis kits, that contain reagents for the synthesis of research grade mRNAs with yield range up to 50,000 µg, are currently available in the market.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

pharmaphorum

DECEMBER 16, 2022

Generative AI drug creation company Absci Corporation has added Dan Rabinovitsj (as pictured), VP of connectivity at Meta, to its Board of Directors. Optibrium, another software developer in the AI drug discovery space, has appointed Ian Smith as its new chief technology officer. AI and robotics hires. McKinnell, Jr.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Drug Discovery World

SEPTEMBER 14, 2023

If you perform all of your tasks manually, you may need to stop your initial run partway through, which means losing the reagents and samples with which you have already begun working. Automation can track logistics, such as adding reagents to a recurring order after a certain amount is used up.

Reagent 111

Reagent Life Science Scientist DNA 111